CD47在卵巢癌进展中的生物作用
Linan Xing1, Zhao Wang2, Yue Feng2
1Department of Gynecology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.
Cancer immunology, immunotherapy : CII
|June 4, 2024
概括
卵巢癌在治疗后经常复发. 针对CD47免疫检查点显示出新免疫疗法的前景,为患有这种致命癌症的患者提供希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 卵巢癌是一种高度致命的恶性瘤,预后不佳.
- 在初始治疗后出现高复发率 (65-80%),没有确立有效的治疗方法.
- CD47/Sirpα免疫检查点是癌症免疫治疗中的关键目标.
研究的目的:
- 审查CD47在卵巢癌中的生物作用.
- 总结CD47在卵巢癌进展和免疫逃避中的机制.
- 突出CD47作为卵巢癌的潜在免疫治疗点.
主要方法:
- 在卵巢癌中对CD47的研究的文献综述.
- 在癌症免疫逃避中分析CD47/Sirpα通路.
- 综合目前关于CD47向治疗的研究.
主要成果:
- CD47在卵巢癌生物学和免疫逃避中发挥着重要作用.
- CD47/Sirpα轴是各种癌症的关键免疫检查点.
- CD47单克隆抗体和相关药物显示出治疗潜力.
结论:
- CD47是卵巢癌免疫治疗的有希望的目标.
- 对CD47向剂的进一步研究是有必要的.
- 未来的临床应用可能包括用于卵巢癌的新型免疫治疗方案.
关键词:
CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47免疫治疗是一种免疫疗法.卵巢癌是发生在卵巢中的癌症.这里是Sirpα酒吧.在TSP-1中使用.更多相关视频
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
6.7K
09:00Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
Published on: December 31, 2015
26.6K
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
